Race, ethnicity, and immune tolerance induction in hemophilia A in the United States

CONCLUSION: Although the role of ITI may evolve with growing use of emicizumab and the introduction of new hemophilia treatment products, understanding characteristics that influence care, particularly race and ethnicity, where physician bias and patient mistrust can occur, will remain relevant and applicable to other complex therapies, including gene therapy.PMID:38193063 | PMC:PMC10772873 | DOI:10.1016/j.rpth.2023.102251

Source: Thrombosis and Haemostasis - January 9, 2024 Category: Hematology Authors: Christine L Kempton Amanda B Payne Stacey A Fedewa Source Type: research